Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine …
2024年8月16日 — Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA …
mRNA Technology: What It Is and How It Works - Pfizer
What is mRNA? How do mRNA therapeutics like the COVID-19 vaccine work? What else can mRNA help us treat? This three-part series answers these questions and more.
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
Today’s actions relate to updated mRNA COVID-19 vaccines manufactured by ModernaTX Inc. and Pfizer Inc. In early June, the FDA advised manufacturers of licensed and authorized …
Pfizer and BioNTech Announce Positive Topline Data for mRNA …
2023年10月26日 — This release contains forward-looking information about Pfizer’s and BioNTech’s mRNA-based combination vaccine candidate for influenza and COVID-19 among …
Pfizer–BioNTech COVID-19 vaccine - Wikipedia
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2][33] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech.
FDA Approves First COVID-19 Vaccine
The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in …
Messenger RNA (mRNA) Vaccines for COVID-19: How Do They …
Messenger RNA (mRNA) vaccines, like the Pfizer and Moderna COVID-19 vaccines, teach cells how to make a protein that triggers an immune response if someone gets infected.
Comparing the differences between COVID-19 vaccines
Pfizer-BioNTech COVID-19 vaccine 2024-2025 formula is authorized for people ages 6 months through 11 years. Comirnaty is approved for people age 12 and older. The vaccines that help …
Pfizer-BioNTech COVID-19 Vaccine | FDA
2024年10月15日 — The Pfizer-BioNTech COVID-19 Vaccine (2024-2025 Formula) is authorized for all doses administered to individuals 6 months through 11 years of age to prevent COVID …
How durable are the mRNA Covid vaccines? - NBC News
2024年11月3日 — Pfizer’s and Moderna’s vaccines were the first to use mRNA technology to induce immunity to a virus, an approach that proved critical in the early days of the pandemic …
How the Pfizer-BioNTech Vaccine Works - The New York Times
The molecule — called mRNA for short — is fragile and would be chopped to pieces by our natural enzymes if it were injected directly into the body. To protect their vaccine, Pfizer and ...
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full …
2020年12月11日 — The FDA-approved COMIRNATY ® (COVID-19 Vaccine, mRNA) and the EUA-authorized Pfizer-BioNTech COVID-19 Vaccine have the same formulation and can be used …
Comparing the COVID-19 Vaccines: How Are They Different?
2024年10月25日 — First introduced in December 2020, the original COVID mRNA vaccines from both Pfizer and Moderna protected against the original SARS-CoV-2 virus. They have been …
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
2020年12月10日 — BNT162b2 is a lipid nanoparticle–formulated, nucleoside-modified RNA vaccine that encodes a prefusion stabilized, membrane-anchored SARS-CoV-2 full-length …
Different types of COVID-19 vaccines: How they work
Both the Pfizer-BioNTech and the Moderna COVID-19 vaccines use mRNA. Vector vaccine. In this type of vaccine, material from the COVID-19 virus is placed in a modified version of a …
COMIRNATY (COVID-19 Vaccine, mRNA) or Pfizer-BioNTech COVID-19 Vaccine, more commonly in adolescent males and adult males under 40 years of age than among females …
Study Largely Confirms Known, Rare COVID-19 Vaccine Side Effects
2024年2月27日 — The Vaccine study confirmed that the Moderna and Pfizer/BioNTech vaccines are linked in rare cases to myocarditis and pericarditis, conditions involving inflammation of the …
At-A-Glance. Guidance below summarizes basic storage, preparation, scheduling, administration, and dosage for all 2024–25 Pfizer-BioNTech COVID-19 vaccine products. Distributed in: Ages: …
Pfizer and BioNTech Receive U.S. FDA Approval & Authorization …
2024年8月22日 — Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA …
Moderna Bivalent COVID-19 Vaccine More Effective at Preventing ...
2024年11月8日 — Moderna's mRNA-1273.222 vaccine showed higher effectiveness than Pfizer-BioNTech's BNT162b2 in preventing COVID-19-related hospitalizations and outpatient …
Fall Vaccine Updates From ACIP: New Recs - Medscape
2024年11月8日 — Adding to the complexity is a new pentavalent vaccine from Pfizer (brand name Penbraya) that combines MenACWY with the MenB vaccine. ... New mRNA Vaccines in …
Pfizer and BioNTech Celebrate Historic First Authorization in the …
2020年12月11日 — NEW YORK & MAINZ, Germany-- (BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug …
Canada approves Moderna's RSV vaccine for those age 60 and …
2024年11月8日 — GSK's Arexvy and Pfizer's shot Abrysvo, both protein-based vaccines, are also approved in Canada for adults aged 60 years and older. ... Moderna says its mRNA vaccine is …
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Discussion. A two-dose regimen of BNT162b2 (30 μg per dose, given 21 days apart) was found to be safe and 95% effective against Covid-19. The vaccine met both primary efficacy end points, …
Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine ...
2020年8月20日 — NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today shared additional Phase 1 safety and …